Jeil Pharmaceutical Co., Ltd. (002620)-Financial and Strategic SWOT Analysis Review

Jeil Pharmaceutical Co., Ltd. (002620)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH30501FSA
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Jeil Pharmaceutical Co., Ltd. (002620)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jeil Pharmaceutical Co., Ltd. (Jeil) is a pharmaceutical company which carries out research, development, manufacturing and commercialization of active pharmaceuticals and finished dosage forms. Its product portfolio includes solid medicines and injections, finished pharmaceutical products including patches, and active pharmaceutical ingredients (APIs). The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others. Jeil exports synthetic ingredients such as Cefditoren Pivoxil and Epinastine HCl, among others to Japan and China. It also exports finished products such as Kefentech Plaster and Cilapenem Injection in ASEAN, Central and South America, Africa and other countries. The company operates a factory and research and development institute in Yongin-si, Gyeonggi-do, Korea. Jeil is headquartered in Seoul, South Korea.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Jeil Pharmaceutical Co., Ltd.-Key Facts 6

Jeil Pharmaceutical Co., Ltd.-Key Employees 7

Jeil Pharmaceutical Co., Ltd.-Major Products and Services 8

Jeil Pharmaceutical Co., Ltd.-Pharmaceutical Pipeline Products Data 9

Jeil Pharmaceutical Co., Ltd., Pipeline Products by Therapy Area 9

Jeil Pharmaceutical Co., Ltd., Pipeline Products by Development Phase 10

Jeil Pharmaceutical Co., Ltd.-History 13

Jeil Pharmaceutical Co., Ltd.-Company Statement 15

Jeil Pharmaceutical Co., Ltd.-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 18

Jeil Pharmaceutical Co., Ltd.-Business Description 18

Jeil Pharmaceutical Co., Ltd.-Corporate Strategy 19

Jeil Pharmaceutical Co., Ltd.-SWOT Analysis 20

SWOT Analysis-Overview 20

Jeil Pharmaceutical Co., Ltd.-Strengths 20

Strength-Wide Range of Products 20

Strength-Focused Research and Development Activities 20

Strength-Lipitor: The Key Contributor 20

Jeil Pharmaceutical Co., Ltd.-Weaknesses 21

Weakness-Declining Cash Reserves 21

Weakness-Increased Credit Risk 21

Jeil Pharmaceutical Co., Ltd.-Opportunities 22

Opportunity-Growing Aged Population in Republic of Korea 22

Opportunity-Promising Product Pipeline 22

Opportunity-Strategic Alliances 22

Jeil Pharmaceutical Co., Ltd.-Threats 23

Threat-Increased Scrutiny of Drug Imports 23

Threat-Competitive Pressures 23

Threat-Stringent Government Regulations 23

Jeil Pharmaceutical Co., Ltd.-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Jeil Pharmaceutical Co., Ltd., Recent Deals Summary 33

Section 5-Appendix 34

Methodology 34

Ratio Definitions 34

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

Jeil Pharmaceutical Co., Ltd., Pipeline Products by Therapy Area 9

Jeil Pharmaceutical Co., Ltd., Pipeline Products by Development Phase 10

Jeil Pharmaceutical Co., Ltd., Performance Chart (2011-2015) 28

Jeil Pharmaceutical Co., Ltd., Ratio Charts 30

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 32

List of Tables

Jeil Pharmaceutical Co., Ltd., Key Facts 6

Jeil Pharmaceutical Co., Ltd., Key Employees 7

Jeil Pharmaceutical Co., Ltd., Major Products and Services 8

Jeil Pharmaceutical Co., Ltd., Number of Pipeline Products by Therapy Area 9

Jeil Pharmaceutical Co., Ltd., Number of Pipeline Products by Development Stage 10

Jeil Pharmaceutical Co., Ltd., Pipeline Products By Therapy Area and Development Phase 11

Jeil Pharmaceutical Co., Ltd., History 13

Jeil Pharmaceutical Co., Ltd., Other Locations 16

Jeil Pharmaceutical Co., Ltd., Key Competitors 24

Jeil Pharmaceutical Co., Ltd., Ratios based on current share price 25

Jeil Pharmaceutical Co., Ltd., Annual Ratios 26

Jeil Pharmaceutical Co., Ltd., Interim Ratios 29

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 31

Jeil Pharmaceutical Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 32

Jeil Pharmaceutical Co., Ltd., Recent Deals Summary 33

Currency Codes 34

Capital Market Ratios 34

Equity Ratios 35

Profitability Ratios 35

Cost Ratios 36

Liquidity Ratios 36

Leverage Ratios 37

Efficiency Ratios 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Jeil Pharmaceutical Co., Ltd., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 19470
Site License
USD 600 INR 38940
Corporate User License
USD 900 INR 58410

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com